Rapidly growing mycobacteria: clinical and microbiologic studies of 115 cases.

We analyzed clinical and microbiologic features of 115 cases involving rapidly growing mycobacteria (RGM) isolated at the University of Texas M.D. Anderson Cancer Center, Houston (2000-2005) and identified by 16S ribosomal RNA gene sequencing analysis. At least 15 RGM species were included: Mycobacterium abscessus (43 strains [37.4%]), Mycobacterium fortuitum complex (33 strains [28.7%]), and Mycobacterium mucogenicum (28 strains [24.3%]) most common, accounting for 90.4%. Most M abscessus (32/43) were isolated from respiratory sources, whereas most M mucogenicum (24/28) were from blood cultures. Antimicrobial susceptibility tests showed that M abscessus was the most resistant species; M mucogenicum was most susceptible. From blood and catheter sources, 46 strains (40.0%) were isolated; 44 represented bacteremia or catheter-related infections. These infections typically manifested high fever (mean temperature, 38.9 degrees C), with a high number of RGM colonies cultured. All infections resolved with catheter removal and antibiotic therapy. Six strains (M abscessus and M fortuitum only) were from skin, soft tissue, and wound infections. There were 59 strains from respiratory sources, and 28 of these represented definitive to probable infections. Prior lung injuries and coisolation of other pathogenic organisms were common. Overall, 78 RGM strains (67.8%) caused true to probable infections without direct deaths.

[1]  M. Tsukamura,et al.  Mycobacterium porcinum sp. nov., a Porcine Pathogen , 1983 .

[2]  R. Wallace,,et al.  Clinical features of pulmonary disease caused by rapidly growing mycobacteria. An analysis of 154 patients. , 1993, The American review of respiratory disease.

[3]  G. Bodey,et al.  Pulmonary disease caused by rapidly growing mycobacteria in patients with cancer. , 1985, Chest.

[4]  Comparison of Methods for Identification ofMycobacterium abscessus and M. chelonae Isolates , 2001, Journal of Clinical Microbiology.

[5]  A. Steigerwalt,et al.  Clinical and Laboratory Features of Mycobacterium porcinum , 2004, Journal of Clinical Microbiology.

[6]  G. Bodey,et al.  Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. , 1991, Reviews of infectious diseases.

[7]  M. Drancourt,et al.  Report of Two Fatal Cases of Mycobacterium mucogenicum Central Nervous System Infection in Immunocompetent Patients , 2006, Journal of Clinical Microbiology.

[8]  R. Wallace,,et al.  Clinical significance, biochemical features, and susceptibility patterns of sporadic isolates of the Mycobacterium chelonae-like organism , 1993, Journal of clinical microbiology.

[9]  C. Kemper,et al.  Mycobacterium Avium Complex , 2017 .

[10]  G. Pfyffer,et al.  Laboratory diagnosis of mycobacterial infections: new tools and lessons learned. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  K. Carroll,et al.  Identification of Mycobacterium spp. by Using a Commercial 16S Ribosomal DNA Sequencing Kit and Additional Sequencing Libraries , 2002, Journal of Clinical Microbiology.

[12]  R. Wallace,,et al.  Clinical Trial of Clarithromycin for Cutaneous (Disseminated) Infection due to Mycobacterium chelonae , 1993, Annals of Internal Medicine.

[13]  J. Tarrand,et al.  Rapid and accurate identification of mycobacteria by sequencing hypervariable regions of the 16S ribosomal RNA gene. , 2002, American journal of clinical pathology.

[14]  T Ezaki,et al.  Proposal of Mycobacterium peregrinum sp. nov., nom. rev., and elevation of Mycobacterium chelonae subsp. abscessus (Kubica et al.) to species status: Mycobacterium abscessus comb. nov. , 1992, International journal of systematic bacteriology.

[15]  Xiang Y. Han Mycobacterium neoaurum Contamination , 2005, Emerging infectious diseases.

[16]  Kenneth,et al.  Mycobacterium wolinskyi sp. nov. and Mycobacterium goodii sp. nov., two new rapidly growing species related to Mycobacterium smegmatis and associated with human wound infections: a cooperative study from the International Working Group on Mycobacterial Taxonomy. , 1999, International journal of systematic bacteriology.

[17]  R. Wallace,,et al.  Clinical and Laboratory Features of Mycobacterium mageritense , 2002, Journal of Clinical Microbiology.

[18]  X. Han Seasonality of clinical isolation of rapidly growing mycobacteria , 2007, Epidemiology and Infection.

[19]  R. Cooksey,et al.  Mycobacterium cosmeticum sp. nov., a novel rapidly growing species isolated from a cosmetic infection and from a nail salon. , 2004, International journal of systematic and evolutionary microbiology.

[20]  M. Truong,et al.  Clinical Significance and Epidemiologic Analyses of Mycobacterium avium and Mycobacterium intracellulare among Patients without AIDS , 2005, Journal of Clinical Microbiology.

[21]  L. Mermel,et al.  Guidelines for the management of intravascular catheter-related infections. , 2001, Infection control and hospital epidemiology.

[22]  C Thornsberry,et al.  Antimicrobial susceptibility of five subgroups of Mycobacterium fortuitum and Mycobacterium chelonae , 1985, Antimicrobial Agents and Chemotherapy.

[23]  E. Tortoli Impact of Genotypic Studies on Mycobacterial Taxonomy: the New Mycobacteria of the 1990s , 2003, Clinical Microbiology Reviews.

[24]  R. Wallace,,et al.  Clinical and Taxonomic Status of Pathogenic Nonpigmented or Late-Pigmenting Rapidly Growing Mycobacteria , 2002, Clinical Microbiology Reviews.

[25]  M. Steinbakk,et al.  Identification of Clinical isolates of Mycobacterium spp. by sequence analysis of the 16S ribosomal RNA gene , 1999, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[26]  R. Wallace,,et al.  Heterogeneity among isolates of rapidly growing mycobacteria responsible for infections following augmentation mammaplasty despite case clustering in Texas and other southern coastal states. , 1989, The Journal of infectious diseases.

[27]  J. Wolfe,et al.  Necessity of Quality-Controlled 16S rRNA Gene Sequence Databases: Identifying Nontuberculous MycobacteriumSpecies , 2001, Journal of Clinical Microbiology.

[28]  R. Wallace,,et al.  Intrinsic Macrolide Resistance in Rapidly Growing Mycobacteria , 2006, Antimicrobial Agents and Chemotherapy.

[29]  A. Steigerwalt,et al.  Mycobacterium septicum sp. nov., a new rapidly growing species associated with catheter-related bacteraemia. , 2000, International journal of systematic and evolutionary microbiology.

[30]  M. Lechevallier,et al.  Factors Influencing Numbers of Mycobacterium avium, Mycobacterium intracellulare, and Other Mycobacteria in Drinking Water Distribution Systems , 2001, Applied and Environmental Microbiology.

[31]  Albert Balows,et al.  Manual of Clinical Microbiology, 7th ed. , 2000 .

[32]  E. Böttger,et al.  Phylogeny of the Mycobacterium chelonae-like organism based on partial sequencing of the 16S rRNA gene and proposal of Mycobacterium mucogenicum sp. nov. , 1995, International journal of systematic bacteriology.

[33]  Nalin Rastogi,et al.  Burden of Unidentifiable Mycobacteria in a Reference Laboratory , 2001, Journal of Clinical Microbiology.

[34]  Wallace Rj The clinical presentation, diagnosis, and therapy of cutaneous and pulmonary infections due to the rapidly growing mycobacteria, M. fortuitum and M. chelonae. , 1989, Clinics in chest medicine.

[35]  E. Böttger,et al.  Differentiation of Mycobacterium species by direct sequencing of amplified DNA. , 1990, Journal of general microbiology.

[36]  K. Yuen,et al.  Identification of Mycobacterium neoaurumIsolated from a Neutropenic Patient with Catheter-Related Bacteremia by 16S rRNA Sequencing , 2000, Journal of Clinical Microbiology.

[37]  M. Arduino,et al.  Mycobacterium goodii Infections Associated with Surgical Implants at Colorado Hospital , 2004, Emerging infectious diseases.

[38]  A. Streifel,et al.  An Outbreak of Bacteremias Associated With Mycobacterium mucogenicum in a Hospital Water Supply , 2004, Infection Control & Hospital Epidemiology.

[39]  G. Stelma,et al.  Occurrence of Nontuberculous Mycobacteria in Environmental Samples , 1999, Applied and Environmental Microbiology.

[40]  R. Wallace,,et al.  Comparison of In Vitro Activities of Gatifloxacin and Ciprofloxacin against Four Taxa of Rapidly Growing Mycobacteria , 2002, Antimicrobial Agents and Chemotherapy.

[41]  J. Tarrand,et al.  Clinical comparison of the resin-containing BACTEC 26 Plus and the Isolator 10 blood culturing systems , 1991, Journal of clinical microbiology.

[42]  A. Steigerwalt,et al.  Taxonomic variation in the Mycobacterium fortuitum third biovariant complex: description of Mycobacterium boenickei sp. nov., Mycobacterium houstonense sp. nov., Mycobacterium neworleansense sp. nov. and Mycobacterium brisbanense sp. nov. and recognition of Mycobacterium porcinum from human clinical , 2004, International journal of systematic and evolutionary microbiology.

[43]  T. Bull,et al.  Mycobacterium mageritense sp. nov. , 1997, International journal of systematic bacteriology.

[44]  M. Luquin,et al.  Mycobacterium brumae sp. nov., a Rapidly Growing, Nonphotochromogenic Mycobacterium , 1993 .

[45]  I. Raad,et al.  Catheter-Related Bloodstream Infection Caused by Mycobacterium brumae , 2004, Journal of Clinical Microbiology.

[46]  J. Musser,et al.  Sequence-Based Identification ofMycobacterium Species Using the MicroSeq 500 16S rDNA Bacterial Identification System , 2000, Journal of Clinical Microbiology.

[47]  R. Good,et al.  Spectrum of disease due to rapidly growing mycobacteria. , 1983, Reviews of infectious diseases.

[48]  J. Domachowske,et al.  First Case Report of Catheter-Related Bacteremia Due to “Mycobacterium lacticola” , 2004, Journal of Clinical Microbiology.

[49]  M. S. Jiménez,et al.  Mycobacterium canariasense sp. nov. , 2004, International journal of systematic and evolutionary microbiology.

[50]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[51]  H. Libshitz,et al.  Clinical and radiological features of pulmonary disease caused by rapidly growing mycobacteria in cancer patients , 2005, European Journal of Clinical Microbiology and Infectious Diseases.

[52]  R. Wallace,,et al.  Susceptibilities of Mycobacterium fortuitum biovar. fortuitum and the two subgroups of Mycobacterium chelonae to imipenem, cefmetazole, cefoxitin, and amoxicillin-clavulanic acid , 1991, Antimicrobial Agents and Chemotherapy.

[53]  C. Hawkins,et al.  Rapidly Progressive Dementia Due to Mycobacterium neoaurum Meningoencephalitis , 2004, Emerging infectious diseases.